Cellebrite DI (CLBT) Total Current Liabilities (2020 - 2025)

Cellebrite DI's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $369.7 million for Q4 2025.

• On a quarterly basis, Total Current Liabilities rose 25.09% year-over-year to $369.7 million in Q4 2025; TTM through Dec 2025 was $369.7 million, a 25.09% increase from a year earlier, with the FY2025 full-year figure at $369.7 million, up 25.09% from the prior year.
• Total Current Liabilities rose to $369.7 million in Q4 2025 per CLBT's latest filing, from $316.9 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $403.7 million in Q3 2021 and bottomed at $170.6 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $235.9 million (2024), against an average of $252.5 million.
• Across the five-year window, Total Current Liabilities tumbled 52.99% in 2022 and surged 30.66% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $186.6 million in 2021, then gained by 11.36% to $207.8 million in 2022, then grew by 22.16% to $253.8 million in 2023, then grew by 16.42% to $295.5 million in 2024, then gained by 25.09% to $369.7 million in 2025.
• Per Business Quant, the three latest CLBT Total Current Liabilities figures stand at $369.7 million (Q4 2025), $316.9 million (Q3 2025), and $310.0 million (Q2 2025).